Cargando…

Correlation between p53 and Mdm2 expression with histopathological parameters in cattle squamous cell carcinomas

BACKGROUND AND AIM: Squamous cell carcinoma (SCC) is the most common form of carcinoma in cattle. Histopathological grading systems have been utilized over several decades for estimating the malignancy of cattle SCCs. This study aimed to detect p53 and Mdm2 expression in different SCC cases in cattl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Jameel, Waseem, Al-Mahmood, S. S., Al-Saidya, A. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Veterinary World 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924381/ https://www.ncbi.nlm.nih.gov/pubmed/35369583 http://dx.doi.org/10.14202/vetworld.2022.10-15

Ejemplares similares

High Expression of MDM2 and the p53 Protein is Predictive Biomarkers for Poor Prognosis of Oesophageal Squamous Cell Carcinoma
por: Ye, Juan, et al.
Publicado: (2021)

Aberrant Expression of pRb, p16, p14ARF, MDM2, p21 and p53 in Squamous Cell Carcinomas of Lung
por: Xue, Qi, et al.
Publicado: (2001)

p16(INK4a )hypermethylation and p53, p16 and MDM2 protein expression in Esophageal Squamous Cell Carcinoma
por: Taghavi, Noushin, et al.
Publicado: (2010)

Energetic Landscape of MDM2-p53 Interactions by Computational Mutagenesis of the MDM2-p53 Interaction
por: Thayer, Kelly M., et al.
Publicado: (2016)

p53 AND MDM2 PROTEIN EXPRESSION IN ACTINIC CHEILITIS
por: de Freitas, Maria da Conceição Andrade, et al.
Publicado: (2008)

Correlation between expression of p53, p21/WAF1, and MDM2 proteins and their prognostic significance in primary hepatocellular carcinoma
por: Zhang, Mei-Fang, et al.
Publicado: (2009)

Expression of p53 at invasive front of oral squamous cell carcinoma and negative histopathological surgical margins to establish correlation at 3-year survival
por: Gawande, Madhuri, et al.
Publicado: (2020)

Regulation of p53: a collaboration between Mdm2 and MdmX
por: Pei, Dongsheng, et al.
Publicado: (2012)

Regulation of kidney development by the Mdm2/Mdm4–p53 axis
por: El-Dahr, Samir, et al.
Publicado: (2017)

The Expression and Correlation of iNOS and p53 in Oral Squamous Cell Carcinoma
por: Yang, Lan, et al.
Publicado: (2015)

Detection of P53 and Mdm2 in vitiligo
por: Wiwanitkit, Viroj
Publicado: (2013)

The MDM2-p53 pathway revisited
por: Nag, Subhasree, et al.
Publicado: (2013)

Evolution of the p53-MDM2 pathway
por: Åberg, Emma, et al.
Publicado: (2017)

Chlamydia infection depends on a functional MDM2-p53 axis
por: González, Erik, et al.
Publicado: (2014)

Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule
por: Grinkevich, Vera V., et al.
Publicado: (2022)

Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
por: Mrkvová, Zuzana, et al.
Publicado: (2019)

Correlations Between DCE MRI and Histopathological Parameters in Head and Neck Squamous Cell Carcinoma()
por: Surov, Alexey, et al.
Publicado: (2016)

CT Texture Analysis—Correlations With Histopathology Parameters in Head and Neck Squamous Cell Carcinomas
por: Meyer, Hans-Jonas, et al.
Publicado: (2019)

Identification of new inhibitors of Mdm2–p53 interaction via pharmacophore and structure-based virtual screening
por: Atatreh, Noor, et al.
Publicado: (2018)

In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases
por: Emanuels, A G, et al.
Publicado: (1999)

The role of MDM2–p53 axis dysfunction in the hepatocellular carcinoma transformation
por: Cao, Hui, et al.
Publicado: (2020)

The Dual Interactions of p53 with MDM2 and p300: Implications for the Design of MDM2 Inhibitors
por: Kannan, Srinivasaraghavan, et al.
Publicado: (2019)

PD-L1 expression correlated with p53 expression in oral squamous cell carcinoma
por: Tojyo, Itaru, et al.
Publicado: (2019)

Expression of MDM2 mRNA, MDM2, P53 and P16 Proteins in Urothelial Lesions in the View of the WHO 4(th) Edition Guidelines as a Molecular Insight towards Personalized Medicine
por: Hammam, Olfat, et al.
Publicado: (2017)

MDM4 expression as an indicator of TP53 reactivation by combined targeting of MDM2 and MDM4 in cancer cells without TP53 mutation
por: Hirose, Mitsuaki, et al.
Publicado: (2014)

Association of epidermal growth factor receptor protein expression with histopathological and clinical parameters in carcinoma of the larynx
por: Vatte, Chittibabu, et al.
Publicado: (2019)

Effects of p53 mutants derived from lung carcinomas on the p53-responsive element (p53RE) of the MDM2 gene.
por: Gorgoulis, V. G., et al.
Publicado: (1998)

A research on the protein expression of p53, p16, and MDM2 in endometriosis
por: Sang, Lin, et al.
Publicado: (2019)

The RP-Mdm2-p53 Pathway and Tumorigenesis
por: Miliani de Marval, Paula L., et al.
Publicado: (2011)

Controlling the Mdm2-Mdmx-p53 Circuit
por: Waning, David L., et al.
Publicado: (2010)

Immunohistochemical detection of P53 and Mdm2 in vitiligo
por: Bakry, Ola A., et al.
Publicado: (2012)

Heterogeneous Hydration of p53/MDM2 Complex
por: Guo, Zuojun, et al.
Publicado: (2014)

Reactivation of p53 via MDM2 inhibition
por: Kim, E S, et al.
Publicado: (2015)

Fortifying p53 – beyond Mdm2 inhibitors
por: Sriraman, Anusha, et al.
Publicado: (2016)

Structural Basis of Competitive Recognition of p53 and MDM2 by HAUSP/USP7: Implications for the Regulation of the p53–MDM2 Pathway
por: Hu, Min, et al.
Publicado: (2006)

p53, MDM2, eIF4E and EGFR expression in nasopharyngeal carcinoma and their correlation with clinicopathological characteristics and prognosis: A retrospective study
por: ZHANG, PENG, et al.
Publicado: (2015)

p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma.
por: Mineta, H., et al.
Publicado: (1998)

FGFR/RACK1 interacts with MDM2, promotes P53 degradation, and inhibits cell senescence in lung squamous cell carcinoma
por: Chen, Tao, et al.
Publicado: (2021)

Nutlin-3, A p53-Mdm2 Antagonist for Nasopharyngeal Carcinoma Treatment
por: Yee-Lin, Voon, et al.
Publicado: (2018)

Correlation of p53 Expression with Histopathological and Immunohistochemical Features of Human Papillomavirus in Oral Leukoplakia
por: Sirur, Dhirendra Gururaj, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_83ulpl787giu6cgot6j2gf9cr9